Screening compound: C24H31N5O2 (S029-0924)

Screening compound: C<sub>24</sub>H<sub>31</sub>N<sub>5</sub>O<sub>2</sub> (S029-0924)
Screening compound: C<sub>24</sub>H<sub>31</sub>N<sub>5</sub>O<sub>2</sub> (S029-0924) alternative view

Chemical Structure Depiction of ChemDiv screening compound
C24H31N5O2 (S029-0924)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S029-0924

Molecular Formula

C24H31N5O2 (C24 H31 N5 O2)

Compound Name

N-cyclopentyl-1'-[(3,5-dimethylisoxazol-4-yl)acetyl]-4,5-dihydrospiro[1,4-benzodiazepine-3,3'-pyrrolidin]-2-amine

IUPAC name

1-[2-(cyclopentylamino)-45-dihydrospiro[14-benzodiazepine-33'-pyrrolidin]-1'-yl]-2-(35-dimethyl-12-oxazol-4-yl)ethan-1-one

SMILES

Cc1noc(C)c1CC(N(CC1)CC11NCc(cccc2)c2N=C1NC1CCCC1)=O

InChI

InChI=1S/C24H31N5O2/c1-16-20(17(2)31-28-16)13-22(30)29-12-11-24(15-29)23(26-19-8-4-5-9-19)27-21-10-6-3-7-18(21)14-25-24/h3,6-7,10,19,25H,4-5,8-9,11-15H2,1-2H3,(H,26,27)/t24-/m0/s1

InChI Key

HAFZQSIDDOSWAC-DEOSSOPVSA-N

MDL Number (MFCD)

MFCD29028496

C24H31N5O2 (S029-0924) in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Bromodomain Modulators Library (5801 compounds)

GPCR Targeted Library (31838 compounds)

Protein-Protein Interaction Library (218420 compounds)

SmartTM Library (51161 compounds)

Spiro Library (21655 compounds)

TLR-8 ligands Library (674 compounds)

Anti-HIV1 Library (19540 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Female
  • Skin
  • Immune system
  • Antiviral
  • Infections
  • Immune system
Targets:
  • Kinases
  • GPCR
  • Others
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
  • Receptor's ligands
Structure:
  • Cyclic compounds
  • Cyclic compounds

References: we are preparing a list of scientific research reports with C24H31N5O2 (S029-0924) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C24H31N5O2 (S029-0924)?
Check Price and Availability of C24H31N5O2 (S029-0924), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C24H31N5O2 (S029-0924) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C24H31N5O2 (S029-0924)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C24H31N5O2 (S029-0924)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C24H31N5O2 (S029-0924) available by request